FBInvestor
Stocks / Relay Therapeutics Inc
Institutional Ownership

Relay Therapeutics Inc

CUSIP 75943R102COMRLAYQ1 2026

13D / 13G Filings
32
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
31.0%
Max % of class reported
Institutional Holders
234
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

32 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Casdin Capital, LLC13G/A7.5%13.00MSEC
2Feb 17, 2026Casdin Capital, LLC13G/A7.5%13.00MSEC
3Nov 14, 2025Commodore Capital LP13G/A11.0%17.00MSEC
4Aug 14, 2025Commodore Capital LP13G/A11.0%13.35MSEC
5Aug 14, 2025Point72 Asset Management, L.P.13G/A7.8%13.45MSEC
6Jul 29, 2025The Vanguard Group13G/A5.5%9.38MSEC
7May 15, 2025Commodore Capital LP13G5.8%10.00MSEC
8Apr 30, 2025The Vanguard Group13G/A7.1%12.11MSEC
9Apr 17, 2025Blackrock, Inc.13G/A6.1%10.31MSEC
10Mar 20, 2025Point72 Asset Management, L.P.13G5.7%9.69MSEC

22 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Relay Therapeutics Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Sb Investment Advisers (Uk) Ltd27.90M$277.65M
2Commodore Capital LP17.00M$169.15M
3Casdin Capital, LLC14.42M$143.46M
4Blackrock, Inc.12.98M$129.10M
5Perceptive Advisors LLC9.75M$97.02M
6Bellevue Group AG7.80M$77.56M
7State Street Corp6.23M$62.02M
8Nextech Invest, Ltd.5.53M$54.99M
9Tcg Crossover Management, LLC4.27M$42.52M
10Fmr LLC3.70M$36.77M